Latest News and Press Releases

ANN ARBOR, Mich., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...

ANN ARBOR, Mich., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...

Ingelheim, Germany and Basel, Switzerland, September 5, 2024 – Boehringer Ingelheim and CDR-Life today announce positive results from the Phase I evaluation of BI 771716 (Study Record |...

RESEARCH TRIANGLE PARK, N.C., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Eclipse Life Sciences, Inc., a privately held clinical-stage biopharmaceutical company focused on the development of novel therapies...

Dublin, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration Market Forecast Report by Disease Type Product Distribution Channel Countries and Company Analysis, 2024-2032" report...

Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global Optometry Equipment Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The global optometry equipment market is...

Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Global Prescription Lens Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...

ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...

PASADENA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, is pleased to announce the publication of important new findings...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetic Retinopathy Market Size, Share & Trends Analysis Report by Type (Proliferative DR, Non-Proliferative DR), Management (Anti-VEGF...